Minarovits J
Microbiological Research Group, National Center for Epidemiology, Budapest, Hungary.
Curr Top Microbiol Immunol. 2006;310:61-80. doi: 10.1007/3-540-31181-5_5.
Epigenotypes are modified cellular or viral genotypes which differ in transcriptional activity in spite of having an identical (or nearly identical) DNA sequence. Restricted expression of latent, episomal herpesvirus genomes is also due to epigenetic modifications. There is no virus production (lytic viral replication, associated with the expression of all viral genes) in tight latency. In vitro experiments demonstrated that DNA methylation could influence the activity of latent (and/or crucial lytic) promoters of prototype strains belonging to the three herpesvirus subfamilies (alpha-, beta-, and gamma-herpesviruses). In vivo, however, DNA methylation is not a major regulator of herpes simplex virus type 1 (HSV-1, a human alpha-herpesvirus) latent gene expression in neurons of infected mice. In these cells, the promoter/enhancer region of latency-associated transcripts (LATs) is enriched with acetyl histone H3, suggesting that histone modifications may control HSV-1 latency in terminally differentiated, quiescent neurons. Epstein-Barr virus (EBV, a human gamma-herpesvirus) is associated with a series of neoplasms. Latent, episomal EBV genomes are subject to host cell-dependent epigenetic modifications (DNA methylation, binding of proteins and protein complexes, histone modifications). The distinct viral epigenotypes are associated with distinct EBV latency types, i.e., cell type-specific usage of latent EBV promoters controlling the expression of latent, growth transformation-associated EBV genes. The contribution of major epigenetic mechanisms to the regulation of latent EBV promoters is variable. DNA methylation contributes to silencing of Wp and Cp (alternative promoters for transcripts coding for the nuclear antigens EBNA 1-6) and LMP1p, LMP2Ap, and LMP2Bp (promoters for transcripts encoding transmembrane proteins). DNA methylation does not control, however, Qp (a promoter for EBNA1 transcripts only) in lymphoblastoid cell lines (LCLs), although in vitro methylated Qp-reporter gene constructs are silenced. The invariably unmethylated Qp is probably switched off by binding of a repressor protein in LCLs.
表观基因型是经过修饰的细胞或病毒基因型,尽管它们具有相同(或几乎相同)的DNA序列,但转录活性却有所不同。潜伏的游离型疱疹病毒基因组的受限表达也归因于表观遗传修饰。在紧密潜伏状态下没有病毒产生(与所有病毒基因表达相关的裂解性病毒复制)。体外实验表明,DNA甲基化可影响属于三个疱疹病毒亚科(α-、β-和γ-疱疹病毒)的原型毒株的潜伏(和/或关键裂解)启动子的活性。然而,在体内,DNA甲基化并不是单纯疱疹病毒1型(HSV-1,一种人类α-疱疹病毒)在受感染小鼠神经元中潜伏基因表达的主要调节因子。在这些细胞中,潜伏相关转录本(LATs)的启动子/增强子区域富含乙酰化组蛋白H3,这表明组蛋白修饰可能控制终末分化的静止神经元中的HSV-1潜伏。爱泼斯坦-巴尔病毒(EBV,一种人类γ-疱疹病毒)与一系列肿瘤相关。潜伏的游离型EBV基因组会发生宿主细胞依赖性表观遗传修饰(DNA甲基化、蛋白质和蛋白质复合物的结合、组蛋白修饰)。不同的病毒表观基因型与不同的EBV潜伏类型相关,即控制潜伏的、与生长转化相关的EBV基因表达的潜伏EBV启动子的细胞类型特异性使用。主要表观遗传机制对潜伏EBV启动子调控的贡献各不相同。DNA甲基化有助于Wp和Cp(编码核抗原EBNA 1-6的转录本的替代启动子)以及LMP1p、LMP2Ap和LMP2Bp(编码跨膜蛋白的转录本的启动子)的沉默。然而,DNA甲基化并不控制淋巴母细胞系(LCLs)中的Qp(仅EBNA1转录本的启动子),尽管体外甲基化的Qp报告基因构建体会被沉默。LCLs中始终未甲基化的Qp可能通过一种阻遏蛋白的结合而被关闭。